Synthesis of Novel -1, 3, 5 - Triazine - Based - Anti-Tuberculosis Drugs.

MSc (Chemistry) === Department of Chemistry === Identification of unique leads represents a significant challenge in drug discovery. This challenge is widely visible in neglected diseases such as tuberculosis, which is an infectious disease caused by bacillus Mycobacterium tuberculosis. The urgent n...

Full description

Bibliographic Details
Main Author: Rapudi, Munaka
Other Authors: Moleele, S. Mnyakeni
Format: Others
Language:en
Published: 2018
Subjects:
Online Access:Rapudi, Munaka (2018) Synthesis of Novel -1, 3, 5 - Triazine - Based - Anti-Tuberculosis Drugs, University of Venda, Thohoyandou, South Africa, <http://hdl.handle.net/11602/1231>
http://hdl.handle.net/11602/1231
id ndltd-netd.ac.za-oai-union.ndltd.org-univen-oai-univendspace.univen.ac.za-11602-1231
record_format oai_dc
spelling ndltd-netd.ac.za-oai-union.ndltd.org-univen-oai-univendspace.univen.ac.za-11602-12312020-05-07T03:17:32Z Synthesis of Novel -1, 3, 5 - Triazine - Based - Anti-Tuberculosis Drugs. Rapudi, Munaka Moleele, S. Mnyakeni Ramaite, I. D. I. Synthesis Drugs Novel Triazine Tuberculosis 616.995 Tuberculosis Tuberculosis -- Prevention Tuberculosis -- Vaccination Triazines Communicable diseases infection Terbtryn Tuberculosis vaccines MSc (Chemistry) Department of Chemistry Identification of unique leads represents a significant challenge in drug discovery. This challenge is widely visible in neglected diseases such as tuberculosis, which is an infectious disease caused by bacillus Mycobacterium tuberculosis. The urgent need in search of new biological entities to fight back TB and drug resistant TB is a drive behind this project. Several specific synthetic protocols have been developed using 1,3,5-triazines due to the important biological properties which they display. The chemistry and an extensive spectrum of biological activities of s-triazines have been examined since several decades and this heterocyclic core has received emerging consensus. Hence, the aim of this project was to synthesize novel anti-TB drugs total with the usage of 1,3,5-triazine as a linker between known anti-TB drugs together with different types of amines. A total of 20 compounds were synthesized, 3 compounds were mono-substituted with an average yield of 75 %, 6 compounds were di-substituted with an average yield of 63 % and 11 compounds were tri-substituted with an average yield of 93 %. Out of 10 compounds which were analysed for biological activity 8 of which showed biological activity against M.smegmatis. Furthermore compound 26 which was hybridized with an amine and a known anti-TB drug inhibited better biological activity. In conclusion the influence of cyanuric chloride in combination with pyrrolidine and anti-TB drugs deserves further study. The newly synthesized compounds were characterized by IR, melting point, GC-MS, biological testing, 1H and 13C NMR. NRF 2018 2018-10-06T07:11:20Z 2018-10-06T07:11:20Z 2018-09-21 Dissertation Rapudi, Munaka (2018) Synthesis of Novel -1, 3, 5 - Triazine - Based - Anti-Tuberculosis Drugs, University of Venda, Thohoyandou, South Africa, <http://hdl.handle.net/11602/1231> http://hdl.handle.net/11602/1231 en University of Venda 1 online resource (v, 65 leaves ; illustrations)
collection NDLTD
language en
format Others
sources NDLTD
topic Synthesis
Drugs
Novel
Triazine
Tuberculosis
616.995
Tuberculosis
Tuberculosis -- Prevention
Tuberculosis -- Vaccination
Triazines
Communicable diseases infection
Terbtryn
Tuberculosis vaccines
spellingShingle Synthesis
Drugs
Novel
Triazine
Tuberculosis
616.995
Tuberculosis
Tuberculosis -- Prevention
Tuberculosis -- Vaccination
Triazines
Communicable diseases infection
Terbtryn
Tuberculosis vaccines
Rapudi, Munaka
Synthesis of Novel -1, 3, 5 - Triazine - Based - Anti-Tuberculosis Drugs.
description MSc (Chemistry) === Department of Chemistry === Identification of unique leads represents a significant challenge in drug discovery. This challenge is widely visible in neglected diseases such as tuberculosis, which is an infectious disease caused by bacillus Mycobacterium tuberculosis. The urgent need in search of new biological entities to fight back TB and drug resistant TB is a drive behind this project. Several specific synthetic protocols have been developed using 1,3,5-triazines due to the important biological properties which they display. The chemistry and an extensive spectrum of biological activities of s-triazines have been examined since several decades and this heterocyclic core has received emerging consensus. Hence, the aim of this project was to synthesize novel anti-TB drugs total with the usage of 1,3,5-triazine as a linker between known anti-TB drugs together with different types of amines. A total of 20 compounds were synthesized, 3 compounds were mono-substituted with an average yield of 75 %, 6 compounds were di-substituted with an average yield of 63 % and 11 compounds were tri-substituted with an average yield of 93 %. Out of 10 compounds which were analysed for biological activity 8 of which showed biological activity against M.smegmatis. Furthermore compound 26 which was hybridized with an amine and a known anti-TB drug inhibited better biological activity. In conclusion the influence of cyanuric chloride in combination with pyrrolidine and anti-TB drugs deserves further study. The newly synthesized compounds were characterized by IR, melting point, GC-MS, biological testing, 1H and 13C NMR. === NRF
author2 Moleele, S. Mnyakeni
author_facet Moleele, S. Mnyakeni
Rapudi, Munaka
author Rapudi, Munaka
author_sort Rapudi, Munaka
title Synthesis of Novel -1, 3, 5 - Triazine - Based - Anti-Tuberculosis Drugs.
title_short Synthesis of Novel -1, 3, 5 - Triazine - Based - Anti-Tuberculosis Drugs.
title_full Synthesis of Novel -1, 3, 5 - Triazine - Based - Anti-Tuberculosis Drugs.
title_fullStr Synthesis of Novel -1, 3, 5 - Triazine - Based - Anti-Tuberculosis Drugs.
title_full_unstemmed Synthesis of Novel -1, 3, 5 - Triazine - Based - Anti-Tuberculosis Drugs.
title_sort synthesis of novel -1, 3, 5 - triazine - based - anti-tuberculosis drugs.
publishDate 2018
url Rapudi, Munaka (2018) Synthesis of Novel -1, 3, 5 - Triazine - Based - Anti-Tuberculosis Drugs, University of Venda, Thohoyandou, South Africa, <http://hdl.handle.net/11602/1231>
http://hdl.handle.net/11602/1231
work_keys_str_mv AT rapudimunaka synthesisofnovel135triazinebasedantituberculosisdrugs
_version_ 1719314356273938432